2026 MIPS Measure #65: Appropriate Treatment for Upper Respiratory Infection (URI)
Percentage of episodes for patients 3 months of age and older with a diagnosis of upper respiratory infection (URI) that did not result in…
Read moreSearch and filter CMS MIPS quality measures by specialty, category, performance year, and reporting method.
Percentage of episodes for patients 3 months of age and older with a diagnosis of upper respiratory infection (URI) that did not result in…
Read moreThe percentage of episodes for patients 3 years and older with a diagnosis of pharyngitis that resulted in an antibiotic order on or within…
Read morePercentage of visits for which the eligible clinician attests to documenting a list of current medications using all immediate resources available on the date…
Read moreIf a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection,…
Read morePercentage of patients 13 years of age and older with a diagnosis of HIV who had tests for syphilis, gonorrhea, and chlamydia performed within…
Read morePercentage of patients aged 12 years and older who were screened for tobacco use one or more times during the measurement period AND who…
Read morePercentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio (IPV), one measles, mumps and rubella…
Read morePercentage of patients, regardless of age, diagnosed with HIV prior to or during the first 90 days of the performance period, with an eligible…
Read morePercentage of patients, regardless of age, with a diagnosis of Human Immunodeficiency Virus (HIV) before or during the first 240 days of the performance…
Read morePercentage of patients, regardless of age, who are active injection drug users who received screening for HCV infection within the 12-month reporting period.
Read moreThe percentage of adolescents 13 years of age who had one dose of meningococcal vaccine (serogroups A, C, W, Y or A, C, W,…
Read morePercentage of patients aged 15-65 at the start of the measurement period who were between 15-65 years old when tested for Human immunodeficiency virus…
Read more